BSELords Mark Industries LtdMediumPositive
Announced Sat, 11 Oct · 12:17 IST

Intimation for News paper coverage of Lord''s Mark Industries Limited earns US FDA nod, boosting India''s global healthcare

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lord's Mark Industries Limited (the strategic investor of Lords Mark India Limited) has secured US FDA registration for its range of surgical consumables, orthopedic supports, and hygiene products. The company's manufacturing facility in Dadra & Nagar Haveli, which employs over 100 professionals across five integrated divisions, produces items like Cotton Crepe Bandages, Elastic Adhesive Bandages, Cannula Fixators, Disinfectant Wet Wipes, abdominal/rib belts, lumbar supports, cervical collars, baby wipes, and more. The facility is already compliant with ISO 13485:2016, WHO-GMP, CDSCO, cGMP, and GLP standards. The US FDA nod opens access to highly regulated markets like the United States, European Union, and the Middle East. The filing also reiterates that the NCLT Mumbai Bench approved the Final Base Resolution Plan on 28th July 2025, and the Registrar of Companies has approved Form INC-28 for the amalgamation of Lord's Mark Industries Limited with Lords Mark India Limited.

Likely market impact

Positive signal for shareholders — the US FDA registration positions the merged entity for export-led growth and entry into global healthcare supply chains, potentially boosting future revenues. The ongoing amalgamation context makes this milestone strategically significant for the company's post-resolution growth trajectory.